
Lisa V. Cook
Examiner (ID: 13949, Phone: (571)272-0816 , Office: P/1678 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1641, 1642, 1678, 1677 |
| Total Applications | 1370 |
| Issued Applications | 805 |
| Pending Applications | 161 |
| Abandoned Applications | 418 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14263635
[patent_doc_number] => 10281376
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-07
[patent_title] => In situ heat induced antigen recovery and staining apparatus and method
[patent_app_type] => utility
[patent_app_number] => 16/102242
[patent_app_country] => US
[patent_app_date] => 2018-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 85
[patent_no_of_words] => 43254
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16102242
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/102242 | In situ heat induced antigen recovery and staining apparatus and method | Aug 12, 2018 | Issued |
Array
(
[id] => 13929067
[patent_doc_number] => 20190048049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => CARGOMERS
[patent_app_type] => utility
[patent_app_number] => 16/100628
[patent_app_country] => US
[patent_app_date] => 2018-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37200
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16100628
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/100628 | CARGOMERS | Aug 9, 2018 | Pending |
Array
(
[id] => 13524565
[patent_doc_number] => 20180313825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => ACTIVATION OF BIOLUMINESCENCE BY STRUCTURAL COMPLEMENTATION
[patent_app_type] => utility
[patent_app_number] => 16/035117
[patent_app_country] => US
[patent_app_date] => 2018-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54586
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16035117
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/035117 | Activation of bioluminescence by structural complementation | Jul 12, 2018 | Issued |
Array
(
[id] => 17316006
[patent_doc_number] => 20210405054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => METHODS FOR DETECTING OVARIAN CANCER
[patent_app_type] => utility
[patent_app_number] => 16/625142
[patent_app_country] => US
[patent_app_date] => 2018-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20738
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16625142
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/625142 | METHODS FOR DETECTING OVARIAN CANCER | Jul 3, 2018 | Abandoned |
Array
(
[id] => 14296965
[patent_doc_number] => 10288605
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-14
[patent_title] => Activation of bioluminescence by structural complementation
[patent_app_type] => utility
[patent_app_number] => 16/023972
[patent_app_country] => US
[patent_app_date] => 2018-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 204
[patent_figures_cnt] => 204
[patent_no_of_words] => 57895
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16023972
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/023972 | Activation of bioluminescence by structural complementation | Jun 28, 2018 | Issued |
Array
(
[id] => 13524561
[patent_doc_number] => 20180313823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => PREDICTION OF FERTILITY IN MALES
[patent_app_type] => utility
[patent_app_number] => 16/024335
[patent_app_country] => US
[patent_app_date] => 2018-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11186
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16024335
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/024335 | PREDICTION OF FERTILITY IN MALES | Jun 28, 2018 | Abandoned |
Array
(
[id] => 15057365
[patent_doc_number] => 10458981
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-29
[patent_title] => Three-step acid dissociation enzyme linked immunosorbent (TADELIS) assay
[patent_app_type] => utility
[patent_app_number] => 16/009369
[patent_app_country] => US
[patent_app_date] => 2018-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9772
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16009369
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/009369 | Three-step acid dissociation enzyme linked immunosorbent (TADELIS) assay | Jun 14, 2018 | Issued |
Array
(
[id] => 16848186
[patent_doc_number] => 20210148931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => COMPOSITIONS AND METHODS FOR PREDICTING POST-SURGICAL CARDIOVASCULAR EVENTS
[patent_app_type] => utility
[patent_app_number] => 16/622499
[patent_app_country] => US
[patent_app_date] => 2018-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4829
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622499
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/622499 | Compositions and methods for predicting post-surgical cardiovascular events | Jun 12, 2018 | Issued |
Array
(
[id] => 13904389
[patent_doc_number] => 20190041399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => MEASURING CIRCULATING THERAPEUTIC ANTIBODY, ANTIGEN AND ANTIGEN/ANTIBODY COMPLEXES USING ELISA ASSAYS
[patent_app_type] => utility
[patent_app_number] => 16/004308
[patent_app_country] => US
[patent_app_date] => 2018-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15862
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16004308
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/004308 | MEASURING CIRCULATING THERAPEUTIC ANTIBODY, ANTIGEN AND ANTIGEN/ANTIBODY COMPLEXES USING ELISA ASSAYS | Jun 7, 2018 | Abandoned |
Array
(
[id] => 13829049
[patent_doc_number] => 20190018009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => DIRECT AFFINITY MEASUREMENT OF HUMAN IGG1 BINDING MULTIMERIC ANTIGENS
[patent_app_type] => utility
[patent_app_number] => 16/003450
[patent_app_country] => US
[patent_app_date] => 2018-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9038
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16003450
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/003450 | DIRECT AFFINITY MEASUREMENT OF HUMAN IGG1 BINDING MULTIMERIC ANTIGENS | Jun 7, 2018 | Abandoned |
Array
(
[id] => 13826685
[patent_doc_number] => 20190016827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => METHOD FOR DETERMINING THE IN VIVO INTERACTION MODE
[patent_app_type] => utility
[patent_app_number] => 16/003475
[patent_app_country] => US
[patent_app_date] => 2018-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12752
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16003475
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/003475 | METHOD FOR DETERMINING THE IN VIVO INTERACTION MODE | Jun 7, 2018 | Abandoned |
Array
(
[id] => 15802925
[patent_doc_number] => 20200124605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => METHOD FOR DETECTION OF LUNG CANCER
[patent_app_type] => utility
[patent_app_number] => 16/620477
[patent_app_country] => US
[patent_app_date] => 2018-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14160
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16620477
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/620477 | METHOD FOR DETECTION OF LUNG CANCER | Jun 6, 2018 | Abandoned |
Array
(
[id] => 17179380
[patent_doc_number] => 11156618
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-10-26
[patent_title] => Rapid measurement of total vitamin D in blood
[patent_app_type] => utility
[patent_app_number] => 15/996955
[patent_app_country] => US
[patent_app_date] => 2018-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 21001
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15996955
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/996955 | Rapid measurement of total vitamin D in blood | Jun 3, 2018 | Issued |
Array
(
[id] => 13593325
[patent_doc_number] => 20180348211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => METHOD FOR REDUCTION OF INTERFERENCES IN IMMUNOASSAYS
[patent_app_type] => utility
[patent_app_number] => 15/995572
[patent_app_country] => US
[patent_app_date] => 2018-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9665
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15995572
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/995572 | Method for reduction of interferences in immunoassays | May 31, 2018 | Issued |
Array
(
[id] => 17808739
[patent_doc_number] => 20220260574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => METHODS OF DETERMINING THERAPIES BASED ON SINGLE CELL CHARACTERIZATION OF CIRCULATING TUMOR CELLS (CTCS) IN METASTATIC DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/617423
[patent_app_country] => US
[patent_app_date] => 2018-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26455
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -54
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16617423
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/617423 | METHODS OF DETERMINING THERAPIES BASED ON SINGLE CELL CHARACTERIZATION OF CIRCULATING TUMOR CELLS (CTCS) IN METASTATIC DISEASE | May 31, 2018 | Abandoned |
Array
(
[id] => 20256338
[patent_doc_number] => 12428681
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-30
[patent_title] => Markers of totipotency and methods of use
[patent_app_type] => utility
[patent_app_number] => 16/616523
[patent_app_country] => US
[patent_app_date] => 2018-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 48
[patent_no_of_words] => 14800
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616523
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616523 | Markers of totipotency and methods of use | May 29, 2018 | Issued |
Array
(
[id] => 16542349
[patent_doc_number] => 20200408763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => Novel stool-based protein biomarkers for colorectal cancer screening
[patent_app_type] => utility
[patent_app_number] => 16/616316
[patent_app_country] => US
[patent_app_date] => 2018-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616316
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616316 | Novel stool-based protein biomarkers for colorectal cancer screening | May 22, 2018 | Abandoned |
Array
(
[id] => 15683713
[patent_doc_number] => 20200096520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => ASSAY FOR PLASMA CELL ASSOCIATED DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/615814
[patent_app_country] => US
[patent_app_date] => 2018-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6072
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615814
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/615814 | ASSAY FOR PLASMA CELL ASSOCIATED DISEASE | May 22, 2018 | Pending |
Array
(
[id] => 13400539
[patent_doc_number] => 20180251812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => COMPOSITIONS AND METHODS FOR IMPROVED NEUROTOXIN ASSAYS
[patent_app_type] => utility
[patent_app_number] => 15/980454
[patent_app_country] => US
[patent_app_date] => 2018-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15409
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15980454
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/980454 | Compositions and methods for improved neurotoxin assays | May 14, 2018 | Issued |
Array
(
[id] => 14132373
[patent_doc_number] => 20190100576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => SIGNAL BIOMARKERS
[patent_app_type] => utility
[patent_app_number] => 15/971633
[patent_app_country] => US
[patent_app_date] => 2018-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17870
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15971633
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/971633 | SIGNAL BIOMARKERS | May 3, 2018 | Abandoned |